WaveMan
WaveMan · Company
BCSF · Bain Capital Specialty Finance, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

BCSF Bain Capital Specialty Finance (BCSF) Insider Trading, Ownership & Congress Trades

Funds & Trusts · Registered investment company · CIK 0001655050
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Bain Capital Specialty Finance insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Bain Capital Specialty Finance, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Rusnak-Carlson Sabrina
General Counsel
BUY
2026-03-03 SEC
2,300
$28.9K
-15.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 24.1% of the 9,560 shares held after it.
  • No other insider bought within 30 days.
Insider activity: General Counsel Rusnak-Carlson Sabrina bought about $28.9K of BCSF on Mar 3, 2026, the largest insider purchase at the company since 2022.
Richer Clare Stack
Director
BUY
2025-03-17 SEC
1,530
$25.1K
-28.6%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 10, 2022.
  • -8.6% median (-8.6% mean) 90-day return after 2 previous buys.
  • The trade is 7.3% of the 20,834 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director Richer Clare Stack bought about $25.1K of BCSF on Mar 17, 2025, the largest insider purchase at the company since 2022.
Richer Clare Stack
Director
BUY
2022-08-10 SEC
3,400
$49.6K
+9.4%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 3, 2022.
  • The trade is 20.3% of the 16,784 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director Richer Clare Stack bought about $49.6K of BCSF on Aug 10, 2022.
Hough Thomas A.
Director
BUY
2022-03-25 SEC
6,271.91
$100.0K
+6.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 22.7% of the 27,679 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Director Hough Thomas A. bought about $100.0K of BCSF on Mar 25, 2022, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
Richer Clare Stack
Director
BUY
2022-03-04 SECtraded 2022-03-03
3,090.02
$50.0K
+10.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 24.2% of the 12,792 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Director Richer Clare Stack bought about $50.0K of BCSF on Mar 3, 2022, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 1 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
2.0% of shares outstanding short · 2.2 days to cover · settled 2026-09-30
below 67% of Funds & Trusts
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch BCSF

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-20.0%12M
-20%-10%-1%+9%2025-102025-122026-022026-042026-062026-082026-10 2026-03-03 · Rusnak-Carlson Sabrina bought $28.9K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BCSF: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in BCSF

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BCSF planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
RCGECATBCATASANMFCRWAYGFMEGITPVGPFXEMOCPZ

BCSF financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
1.39x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
0.09x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
+5.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
10.15x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$2.1B
market value at close 2026-10-26 on 2026-08-10 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing EPS growth -40%, PEG needs growth
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Net income$98.8M$119.4M$123.4M$105.5M
EPS (diluted)1.531.851.911.63
Operating cash flow$29.5M-$27.1M$219.3M-$316.8M
Cash$23.1M$51.6M$43.0M$30.2M
Long-term debt$1.5B$1.4B$1.3B$1.4B
Dividends paid$145.8M$114.3M$99.4M$87.8M
SEC XBRL, fiscal years, as known on 2026-10-27

BCSF Stock Sonar score 3/7 axes

Find similar shapesCompare

BCSF ranks highest on profitability (62nd percentile) and risk and compliance (60th), and lowest on financial health (33rd), among Funds & Trusts peers.

Profitability
62
Inputs
  • Return on equity+5.8% · 64 pct, sector of 37
  • Return on assets+2.4% · 59 pct, sector of 38
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Financial health
33
Inputs
  • Debt to equity1.39x · 18 pct, universe of 3,589
  • Cash flow to debt0.09x · 48 pct, sector of 30
Risk and compliance
60
Inputs
  • Short interest, % of shares outstanding (no float on file)+2.0% · 60 pct, sector of 46
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Growth, Insider conviction, Institutional and government, US patents
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies